technetium tc 99m sestamibi has been researched along with ly335979 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dahlheimer, J; Piwnica-Worms, D; Slapak, CA | 1 |
| Bates, SF; Chen, C; Figg, WD; Fojo, T; Kang, M; Robey, R | 1 |
2 review(s) available for technetium tc 99m sestamibi and ly335979
| Article | Year |
|---|---|
Reversal of multidrug resistance with LY335979: functional analysis of P-glycoprotein-mediated transport activity and its modulation in vivo.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; Dibenzocycloheptenes; Drug Resistance, Multiple; Genes, MDR; Humans; Quinolines; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2001 |
Reversal of multidrug resistance: lessons from clinical oncology.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzazepines; Clinical Trials as Topic; Cyclosporins; Dibenzocycloheptenes; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Fluorescent Dyes; Gene Expression Regulation, Neoplastic; Genes, MDR; Humans; Mice; Mice, Knockout; Neoplasm Proteins; Neoplasms; Piperidines; Pyridines; Quinolines; Radionuclide Imaging; Radiopharmaceuticals; Rhodamines; Technetium Tc 99m Sestamibi; Tissue Distribution; Tumor Cells, Cultured | 2002 |